Warner Fiona J, Miller Robert C, Burcher Elizabeth
Department of Physiology and Pharmacology, University of New South Wales, Sydney, Australia.
Biochem Pharmacol. 2002 Jun 15;63(12):2181-6. doi: 10.1016/s0006-2952(02)01014-6.
A structure-activity study of the neurokinin A (NKA) fragment NKA(4-10) was performed to investigate the importance of amino acid residues for receptor efficacy, potency and affinity at the NK(2) receptor in human colon circular muscle. Fourteen analogs of NKA(4-10) were produced with substitutions at positions 4, 5, 7, 9 and/or 10 of NKA. Their potencies were determined by in vitro contractile responses and affinities by radioligand binding using [125I]NKA. Functional potency was enhanced 8-fold by single amino acid substitutions with Lys(5) and MeLeu(9) but not significantly altered by substitutions Glu(4), Arg(5), His(5) and Nle(10). The multiply-substituted analogs [MeLeu(9),Nle(10)]NKA(4-10), [Lys(5),MeLeu(9),Nle(10)]NKA(4-10) and [Lys(5),(Tyr(7)),MeLeu(9),Nle(10)]NKA(4-10) displayed 6-9-fold increase in potency. Although [Arg(5),Nle(10)]NKA(4-10) was similar in potency to NKA(4-10), it was the only analog to show significantly reduced efficacy. All analogs were able to compete fully for [125I]NKA binding. [Lys(5),MeLeu(9)]NKA(4-10), [MeLeu(9),Nle(10)]NKA(4-10), [Lys(5),Nle(10)]NKA(4-10) and analogs containing single substitutions with Glu(4), Arg(5), Lys(5) and MeLeu(9) displayed significantly higher affinity, whereas those with Nle(10) and [Glu(4),Nle(10)] substitutions showed significantly lower affinity than NKA(4-10). There was a positive correlation (r=0.63) between binding affinity and functional potency, which was markedly improved (r=0.95) by removal of three analogs: [Lys(5),MeLeu(9),Nle(10)]NKA(4-10), [Lys(5),Tyr(7),MeLeu(9),Nle(10)]NKA(4-10) and [Lys(5),Tyr(I(2))(7),MeLeu(9),Nle(10)]NKA(4-10). These exhibited similar binding affinities to that of NKA(4-10) but were more potent in functional studies, possibly indicating a different mechanism of receptor interaction. In conclusion, substitution of Ser(5) with Lys, and/or N-methylation of Leu(9), were the most effective changes to increase functional and binding potency of NKA(4-10) at the human colon NK(2) receptor.
进行了神经激肽A(NKA)片段NKA(4 - 10)的构效关系研究,以探讨氨基酸残基对人结肠环行肌中NK(2)受体的受体效能、效价和亲和力的重要性。制备了14种NKA(4 - 10)类似物,它们在NKA的第4、5、7、9和/或10位发生了取代。通过体外收缩反应测定它们的效价,使用[125I]NKA通过放射性配体结合测定亲和力。用赖氨酸(Lys)(5)和甲基亮氨酸(MeLeu)(9)进行单氨基酸取代可使功能效价提高8倍,但谷氨酸(Glu)(4)、精氨酸(Arg)(5)、组氨酸(His)(5)和正亮氨酸(Nle)(10)取代并未显著改变其效价。多重取代类似物[MeLeu(9),Nle(10)]NKA(4 - 10)、[Lys(5),MeLeu(9),Nle(10)]NKA(4 - 10)和[Lys(5),(酪氨酸(Tyr)(7)),MeLeu(9),Nle(10)]NKA(4 - 10)的效价提高了6 - 9倍。尽管[Arg(5),Nle(10)]NKA(4 - 10)的效价与NKA(4 - 10)相似,但它是唯一显示效能显著降低的类似物。所有类似物都能完全竞争[125I]NKA的结合。[Lys(5),MeLeu(9)]NKA(4 - 10)、[MeLeu(9),Nle(10)]NKA(4 - 10)、[Lys(5),Nle(10)]NKA(4 - 10)以及含有谷氨酸(Glu)(4)、精氨酸(Arg)(5)、赖氨酸(Lys)(5)和甲基亮氨酸(MeLeu)(9)单取代的类似物表现出显著更高的亲和力,而那些具有正亮氨酸(Nle)(10)和[Glu(4),Nle(10)]取代的类似物显示出比NKA(4 - 10)显著更低的亲和力。结合亲和力与功能效价之间存在正相关(r = 0.63),去除三种类似物:[Lys(5),MeLeu(9),Nle(10)]NKA(4 - 10)、[Lys(5),酪氨酸(Tyr)(7),MeLeu(9),Nle(10)]NKA(4 - 10)和[Lys(5),酪氨酸(Tyr)(I(2))(7),MeLeu(9),Nle(10)]NKA(4 - 10)后,这种相关性显著改善(r = 0.95)。这些类似物表现出与NKA(4 - 10)相似的结合亲和力,但在功能研究中更有效,这可能表明受体相互作用的机制不同。总之,用赖氨酸取代丝氨酸(Ser)(5)和/或亮氨酸(Leu)(9)的N - 甲基化是增加NKA(4 - 10)在人结肠NK(2)受体上的功能和结合效价的最有效变化。